S-nitrosothiols, nitric oxide and proinflammatory cytokines in children with inflammatory bowel disease

S A Kolesov1, L V Korkotashvili, A B Yazykova

  • 1Federal State Institution "Nizhny Novgorod Research Institute of Children Gastroenterology", Laboratory Department, Nizhny Novgorod, Russia. sakdom2@gmail.com

Clinical Laboratory
|November 27, 2013
PubMed

Insights

Children with inflammatory bowel disease (IBD) show elevated S-nitrosothiols (RSNO) in blood serum. These findings suggest RSNO plays a role in pediatric IBD development.

Area of Science:

  • Pediatric Gastroenterology
  • Biochemistry
  • Immunology

Background:

  • Inflammatory bowel disease (IBD) encompasses Crohn's disease (CD) and ulcerative colitis (UC).
  • Nitric oxide (NO) metabolism is implicated in IBD pathogenesis.
  • S-nitrosothiols (RSNO) are key NO metabolites with diverse biological functions.

Purpose of the Study:

  • To investigate S-nitrosothiol (RSNO) levels in pediatric IBD patients.
  • To correlate RSNO levels with nitric oxide metabolites (NOx) and proinflammatory cytokines (PC).
  • To explore the role of RSNO in the pathogenesis of pediatric IBD.

Main Methods:

  • Serum samples from 174 children (112 IBD, 62 controls) aged 6-17 years were analyzed.
  • S-nitrosothiols (RSNO) and NOx were quantified using the Griess method.
  • Proinflammatory cytokines (PC) were measured via ELISA; data analyzed using Statistica 6.1.

Main Results:

  • Elevated, though not statistically significant, RSNO levels were observed in children with nonspecific ulcerative colitis (NUC) and Crohn's disease (CD).
  • No correlation was found between RSNO and total nitric oxide (NO) levels.
  • A unidirectional correlation was observed between RSNO and proinflammatory cytokine (PC) levels.

Conclusions:

  • RSNO concentrations in pediatric IBD patients suggest their involvement in disease pathogenesis.
  • Findings indicate an indirect link between aberrant nitric oxide synthase activity and RSNO formation in pediatric IBD.
  • RSNO may serve as a biomarker or therapeutic target in pediatric IBD.
Abstract

Related Concept Videos

Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
69
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
57
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease II: Crohn's Disease01:30

Inflammatory Bowel Disease II: Crohn's Disease

Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.6K
Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79